NPY6R expression was associated with metabolic reprogramming in colon cancer (WP), epithelial to mesenchymal transition in colorectal cancer (WP), bladder cancer (KEGG), and constitutive signaling by aberrant PI3K in cancer (REACTOME), which suggests that NPY6R is associated with tumor progression in UVM. This evidence concerns the gene NPY6R and neoplasm.